Particularly in NSCLC, RhoB expression was lost in tumors with concurrent loss of p27 and maintained in tumors expressing wild-type p27 or p27CK− , a mutant that cannot inhibit CDKs. Here, RHOB is linked to non-small cell lung carcinoma.